Galluppi Stefan's Form 4/A amendment
AmendedLifeMD, Inc. (LFMD) · filed May 31, 2023
- Accession no.
- 0001362118-23-000035
- Filed
- May 31, 2023
- Trade date
- May 23, 2023
- Filing delay
- 8 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 23, 2023
This filing lists 1 non-derivative transaction. Open-market purchases total $10.0K. It was filed 8 days after the trade.
This amendment replaces 0001362118-23-000032 (filed May 23, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galluppi StefanCIK 0001722649 | Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | Common Stock, par value $0.01 | PPurchaseAcquired | +4,608 | $2.17 | +$9,999.36 | 12,449 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4 corrects the number of shares purchased.